File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/ng0396-280
- Scopus: eid_2-s2.0-13344282728
- PMID: 8589719
- WOS: WOS:A1996TY18300017
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor
Title | Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor |
---|---|
Authors | |
Issue Date | 1996 |
Publisher | Nature Publishing Group. The Journal's web site is located at http://www.genetics.nature.com |
Citation | Nature Genetics, 1996, v. 12 n. 3, p. 280-287 How to Cite? |
Abstract | Mice that have been made deficient for the cystic fibrosis transmembrane conductance regulator (Cftr) usually die of intestinal obstruction. We have created Cftr-deficient mice and demonstrate prolonged survival among backcross and intercross progeny with different inbred strains, suggesting that modulation of disease severity is genetically determined. A genome scan showed that the major modifier locus maps near the centromere of mouse chromosome 7. Electrophysiological studies on mice with prolonged survival show that the partial rectification of Cl- and Na+ ion transport abnormalities can be explained in part by up-regulation of a calcium- activated Cl- conductance. Identification of modifier genes in our Cftr(m1HSC)/Cftr(m1HSC) mice should provide important insight into the heterogeneous disease presentation observed among CF patients. |
Persistent Identifier | http://hdl.handle.net/10722/44297 |
ISSN | 2023 Impact Factor: 31.7 2023 SCImago Journal Rankings: 17.300 |
ISI Accession Number ID | |
References | |
Errata |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rozmahel, R | en_HK |
dc.contributor.author | Wilschanski, M | en_HK |
dc.contributor.author | Matin, A | en_HK |
dc.contributor.author | Plyte, S | en_HK |
dc.contributor.author | Oliver, M | en_HK |
dc.contributor.author | Auerbach, W | en_HK |
dc.contributor.author | Moore, A | en_HK |
dc.contributor.author | Forstner, J | en_HK |
dc.contributor.author | Durie, P | en_HK |
dc.contributor.author | Nadeau, J | en_HK |
dc.contributor.author | Bear, C | en_HK |
dc.contributor.author | Tsui, LC | en_HK |
dc.date.accessioned | 2007-09-12T03:50:52Z | - |
dc.date.available | 2007-09-12T03:50:52Z | - |
dc.date.issued | 1996 | en_HK |
dc.identifier.citation | Nature Genetics, 1996, v. 12 n. 3, p. 280-287 | en_HK |
dc.identifier.issn | 1061-4036 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/44297 | - |
dc.description.abstract | Mice that have been made deficient for the cystic fibrosis transmembrane conductance regulator (Cftr) usually die of intestinal obstruction. We have created Cftr-deficient mice and demonstrate prolonged survival among backcross and intercross progeny with different inbred strains, suggesting that modulation of disease severity is genetically determined. A genome scan showed that the major modifier locus maps near the centromere of mouse chromosome 7. Electrophysiological studies on mice with prolonged survival show that the partial rectification of Cl- and Na+ ion transport abnormalities can be explained in part by up-regulation of a calcium- activated Cl- conductance. Identification of modifier genes in our Cftr(m1HSC)/Cftr(m1HSC) mice should provide important insight into the heterogeneous disease presentation observed among CF patients. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Nature Publishing Group. The Journal's web site is located at http://www.genetics.nature.com | en_HK |
dc.relation.ispartof | Nature Genetics | en_HK |
dc.subject.mesh | Chlorides - metabolism | en_HK |
dc.subject.mesh | Cystic fibrosis - genetics - pathology - physiopathology | en_HK |
dc.subject.mesh | Cystic fibrosis transmembrane conductance regulator - deficiency - genetics | en_HK |
dc.subject.mesh | Ileum - pathology | en_HK |
dc.subject.mesh | Disease models, animal | en_HK |
dc.title | Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Tsui, LC: tsuilc@hkucc.hku.hk | en_HK |
dc.identifier.authority | Tsui, LC=rp00058 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_HK |
dc.identifier.doi | 10.1038/ng0396-280 | en_HK |
dc.identifier.pmid | 8589719 | en_HK |
dc.identifier.scopus | eid_2-s2.0-13344282728 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-13344282728&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 12 | en_HK |
dc.identifier.issue | 3 | en_HK |
dc.identifier.spage | 280 | en_HK |
dc.identifier.epage | 287 | en_HK |
dc.identifier.isi | WOS:A1996TY18300017 | - |
dc.publisher.place | United States | en_HK |
dc.relation.erratum | eid:eid_2-s2.0-0030000483 | - |
dc.identifier.scopusauthorid | Rozmahel, R=6701510561 | en_HK |
dc.identifier.scopusauthorid | Wilschanski, M=6701812857 | en_HK |
dc.identifier.scopusauthorid | Matin, A=35581268900 | en_HK |
dc.identifier.scopusauthorid | Plyte, S=6701650532 | en_HK |
dc.identifier.scopusauthorid | Oliver, M=16157886700 | en_HK |
dc.identifier.scopusauthorid | Auerbach, W=6701322806 | en_HK |
dc.identifier.scopusauthorid | Moore, A=7402762852 | en_HK |
dc.identifier.scopusauthorid | Forstner, J=7006092197 | en_HK |
dc.identifier.scopusauthorid | Durie, P=7005360997 | en_HK |
dc.identifier.scopusauthorid | Nadeau, J=7102010316 | en_HK |
dc.identifier.scopusauthorid | Bear, C=7006718679 | en_HK |
dc.identifier.scopusauthorid | Tsui, LC=7102754167 | en_HK |
dc.identifier.issnl | 1061-4036 | - |